about
[Parkinsonism or Parkinson's disease unmasked by pentoxifylline?]Neuroleptic malignant syndrome-like, or--dopaminergic malignant syndrome--due to levodopa therapy withdrawal. Clinical features in 11 patients.Use of primidone in low doses (250 mg/day) versus high doses (750 mg/day) in the management of essential tremor. Double-blind comparative study with one-year follow-up.High-altitude headache.Satisfaction with Life Scale (SLS-6): First validation study in Parkinson's disease population.New diagnostic criteria for neurocysticercosis: Reliability and validity.Care of patients with Huntington's disease in South America: a survey.Reflex sympathetic syndrome and peripheral dystonia.Cross-cultural validation of the Scales for Outcomes in Parkinson's Disease-Psychosocial questionnaire (SCOPA-PS) in four Latin American countries.Fluoxetine-induced tremor: clinical features in 21 patients.Psychometric attributes of the rating scale for gait evaluation in Parkinson's disease.Cross-cultural evaluation of the modified Parkinson Psychosis Rating Scale across disease stages.Tuberculous meningitis and dystonia.Dementia associated with Parkinson's disease: applying the Movement Disorder Society Task Force criteria.Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale.Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson's disease.Concurrent validation of the 21-item and 6-item Hamilton Depression Rating Scale versus the DSM-IV diagnostic criteria to assess depression in patients with Parkinson's disease: an exploratory analysis.Two questionnaires for Parkinson's disease: are the PDQ-39 and PDQL equivalent?Delirium in Parkinson's disease patients. a five-year follow-up study.Psychometric characteristics of PIMS--compared to PDQ-39 and PDQL--to evaluate quality of life in Parkinson's disease patients: validation in Spanish (Ecuadorian style).Positive Association of the Cathepsin D Ala224Val Gene Polymorphism With the Risk of Alzheimer's Disease.Case series of Creutzfeldt-Jakob disease in a third-level hospital in Quito.High altitude headache. A prospective study of its clinical characteristicsFatigue in Parkinson's disease: Metric properties of the fatigue impact scale for daily use (D-FIS), and its impact on quality of life[Chronic tension-type headache and depression]Parkinson's and migraine
P50
Q32105039-3BB18D82-1D80-498C-94B5-DBE5D39F1D4CQ34531107-D6DD1D37-C17F-4DB6-8307-7B234DF1C0CBQ34542077-F92CBA37-74F3-44E5-ACD4-80D59A92065FQ36752919-EC074818-892B-4956-BF84-F1768D09D4A7Q40893977-641AA213-197C-4B6C-9138-C1EA0E438940Q41349963-BB7CD8A1-2CEA-42E0-932B-9FF40FB82AD0Q43847932-B9C8EC8C-9375-4D9B-AD77-BA0E6C978C12Q44611403-D52BA4DF-4FC5-4033-BEEE-0BFE7FE246D8Q44650128-11060735-A72D-4257-850A-9BB5B8EF7859Q44920810-F870B503-14D4-418A-A5F3-66E9BA933563Q45333704-D4BB5727-591E-4D32-B32F-16FDC02AE03DQ47400624-8728E734-E666-4C8C-8276-5D496B8433ACQ48856893-EE028F7F-3520-4476-B166-9D606E965F97Q50797645-2B533E72-4244-4E8E-A7FF-0789899367CCQ51766764-8820AEBD-6085-42D8-8BF1-9C5AB830F21BQ51846650-88713302-9C96-4F0F-BC34-26E31E002BA1Q51897758-AF011FB0-3631-42BA-BD60-BEDE9AD467EFQ51903166-0985F82F-7119-43F8-883D-8273B2BA4689Q51926758-0F011246-0F2A-48C2-9B2B-4A7864B32B4DQ53178131-3F429F5A-92DB-46A7-B244-4DBAEB3BDFB0Q53367922-8A1FA110-D6F7-44E5-B0A6-5EC51D38CDBEQ55302403-798F82D7-2A77-41D4-A854-6430F8FA5B09Q57107034-EB563D4C-DCEC-4FA1-A000-294EE4ADC618Q64917932-F863E31B-2E2A-4C92-ADA9-78766F4FBBD3Q73931718-5941B362-B183-4688-92A4-A0B00CE7DE00Q74451595-AAAE1CFE-8C6E-4FCD-AF0C-4D590D4A3B71
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marcos Serrano-Dueñas
@ast
Marcos Serrano-Dueñas
@en
Marcos Serrano-Dueñas
@es
Marcos Serrano-Dueñas
@nl
Marcos Serrano-Dueñas
@sl
type
label
Marcos Serrano-Dueñas
@ast
Marcos Serrano-Dueñas
@en
Marcos Serrano-Dueñas
@es
Marcos Serrano-Dueñas
@nl
Marcos Serrano-Dueñas
@sl
prefLabel
Marcos Serrano-Dueñas
@ast
Marcos Serrano-Dueñas
@en
Marcos Serrano-Dueñas
@es
Marcos Serrano-Dueñas
@nl
Marcos Serrano-Dueñas
@sl
P1053
E-8845-2015
P106
P1153
24734442400
7003970369
P1960
TtEZlqAAAAAJ
P2038
Marcos_Serrano-Duenas
P21
P31
P3829
P4012
P496
0000-0002-4496-6654